Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Open-market sale Chief Scientific Officer sold 2,136 shares at $31.34 ($66,942)
  2. 4 Planned sale Chief Medical Officer sold 2,636 shares at $31.27 ($82,428)
  3. 4 Planned sale Chief Operating Officer sold 85,270 shares at an average $30.30 ($2,583,782)
  4. 4 Open-market sale Chief Business Officer sold 1,823 shares at $31.34 ($57,133)
  5. 4 Planned sale SVP, Head of Finance & Admin. sold 2,921 shares at an average $30.74 ($89,779)
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 8-K Event Shareholder vote results
  19. 4 Planned sale Chief Scientific Officer sold 30,426 shares at an average $32.96 ($1,002,751)
  20. 424B5 Offering Prospectus

Page 20 of 40 · 796 filings